Patterns of Relapse and Risk Reduction Following Tumor Debulking by Bridging Radiotherapy prior to Chimeric Antigen Receptor T Cell Therapy in Non-Hodgkin Lymphoma.
Saved in:
| Title: | Patterns of Relapse and Risk Reduction Following Tumor Debulking by Bridging Radiotherapy prior to Chimeric Antigen Receptor T Cell Therapy in Non-Hodgkin Lymphoma. |
|---|---|
| Authors: | Hubbeling, H.G.1 (AUTHOR), Silverman, E.A.1 (AUTHOR), Michaud, L.2 (AUTHOR), Flynn, J.1 (AUTHOR), Devlin, S.1 (AUTHOR), Wijetunga, N.A.1 (AUTHOR), Tomas, A. Alarcon1 (AUTHOR), Shouval, R.1 (AUTHOR), Palomba, M.L.1 (AUTHOR), Batlevi, C.L.1 (AUTHOR), Dahi, P.B.1 (AUTHOR), Park, J.H.1 (AUTHOR), Scordo, M.1 (AUTHOR), Sauter, C.S.1 (AUTHOR), Shah, G.L.1 (AUTHOR), Schoder, H.2 (AUTHOR), Perales, M.A.1 (AUTHOR), Hajj, C.1 (AUTHOR), Yahalom, J.1 (AUTHOR), Imber, B.S.1 (AUTHOR) |
| Source: | International Journal of Radiation Oncology, Biology, Physics. 2022 Supplement, Vol. 114 Issue 3, pS135-S136. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 03603016 |
|---|---|
| DOI: | 10.1016/j.ijrobp.2022.07.596 |
